These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3128405)

  • 21. Effect of thyrotropin-releasing hormone on the neurologic impairment in rats with spinal cord injury: treatment starting 24 h and 7 days after injury.
    Hashimoto T; Fukuda N
    Eur J Pharmacol; 1991 Oct; 203(1):25-32. PubMed ID: 1797554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRH and diseases of the motor system.
    Munsat TL; Lechan R; Taft JM; Jackson IM; Reichlin S
    Ann N Y Acad Sci; 1989; 553():388-98. PubMed ID: 2497682
    [No Abstract]   [Full Text] [Related]  

  • 23. Down-regulation of thyrotropin-releasing hormone (TRH) receptors in spinal cord after transection as revealed by quantitative autoradiography.
    Vita G; Haun CK; Hawkins EF; Engel WK
    Exp Brain Res; 1991; 83(2):381-4. PubMed ID: 1850699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathology of experimental spinal cord trauma. Comparison of treatment with TRH, naloxone, and dexamethasone.
    Akdemir H; Paşaoğlu A; Oztürk F; Selçuklu A; Koç K; Kurtsoy A
    Res Exp Med (Berl); 1992; 192(3):177-83. PubMed ID: 1636062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI; Hallenbeck JM; Brown CQ
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical treatment of acute spinal cord injuries.
    Ceylan S; Kalelioğlu M; Aktürk G; Aktürk F; Ceylan S
    Res Exp Med (Berl); 1990; 190(2):111-9. PubMed ID: 2112263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotrophin-releasing hormone. New applications in the clinic.
    Griffiths EC
    Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448
    [No Abstract]   [Full Text] [Related]  

  • 28. Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain?
    Metcalf G; Dettmar PW
    Lancet; 1981 Mar; 1(8220 Pt 1):586-9. PubMed ID: 6110823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate antagonist in traumatic shock.
    McIntosh TK; Faden AI
    Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy.
    Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N
    J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrotropin-releasing hormone for spinal trauma.
    Hall ED; Braughler JM
    N Engl J Med; 1982 Feb; 306(7):429-30. PubMed ID: 6799827
    [No Abstract]   [Full Text] [Related]  

  • 33. Opiate antagonists in shock and trauma.
    Holaday JW
    Am J Emerg Med; 1984 Jan; 2(1):8-12. PubMed ID: 6097276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of thyrotropin-releasing hormone (TRH) in experimental spinal cord injury: a quantitative histopathologic study.
    Takami K; Hashimoto T; Shino A; Fukuda N
    Jpn J Pharmacol; 1991 Nov; 57(3):405-17. PubMed ID: 1813666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
    Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
    Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 38. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: possible clinical implications.
    Hawkins EF; Engel WK
    Life Sci; 1985 Feb; 36(6):601-11. PubMed ID: 2982071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of thyrotropin-releasing hormone on the time course of neurologic recovery after spinal cord injury in the rat.
    Hashimoto T; Fukuda N
    Jpn J Pharmacol; 1990 Aug; 53(4):479-86. PubMed ID: 2120495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs.
    Monga V; Meena CL; Kaur N; Jain R
    Curr Med Chem; 2008; 15(26):2718-33. PubMed ID: 18991632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.